United States Vaccine Market Analysis Report by Renub Research

The average human life span has grown significantly primarily due to vaccination. Vaccines have transformed public health throughout the world, especially for children. In the United States, among the various diseases like Influenza, Rotavirus, Hepatitis (Hepatitis A and Hepatitis B), Polio, DTap, HIB, Pneumococcal conjugate, Varicella, MMR and HPV, influenza is the most common viral infection. Quadrivalent is the most common flu vaccines in the United States, which was licensed in the year 2012. According to Renub Research, United States Vaccine Market is poised to reach US$ 11.4 Billion by 2026.

Although influenza can catch anyone anytime in the year, usually it spreads between May to October. So in August National Immunization Awareness day is being celebrated to increase the awareness and also the importance of vaccination in the nation. These immunizations awareness and government initiatives have helped to prevent 2-3 million deaths annually consistent with the WHO. there’s no other health intervention as simple, powerful, and cost-effective as a ‘vaccine’.

A vaccine is a biological preparation that gives active acquired immunity against a selected disease. A vaccine consists of an agent that resembles or maybe a part of the disease-causing microorganism and is often made from weakened or killed kinds of the organism, its toxins, or one of its surface proteins. The agent triggers the body’s immune system to acknowledge the agent as a threat, destroy it, and to recognize further and destroy any of the microorganisms related to that agent that it should encounter in the future.

In this report, we have studied key players like GlaxoSmithKline, plc, Merck & Co, Sanofi Pasteur and Pfizer, Inc their trends and implication which has given these companies to view in a strategic way. Apart from that, companies are evaluated on parameters like

• Overviews
• Recent Developments
• Revenues
• Vaccinations Pipeline & Clinical Trials

Renub Research report titled “United States Vaccine Market By Vaccine Type (Vaccines Market, Immunized Population and Administered Doses), Influenza (Trivalent Flu Vaccine and Quadrivalent Flu Vaccine), Retrovirus, Hepatitis (Hepatitis A and B), Polio, DTap, HIB, Pneumococcal Conjugate, Varicella, MMR and HPV) Vaccines Products and Pipeline, Company Analysis (GlaxoSmithKline, plc, Merck & Co, Sanofi Pasteur and Pfizer, Inc.)” provides an all-encompassing analysis on the United States Vaccine Industry.

Request a free Sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=united-states-vaccine-market-p.php

All the 10 Vaccines have been studied from 3 points

• Vaccines Market
• Immunized Population (Infants)
• Doses of Vaccines Administered

Vaccine Type – The Report Covers the Market, Immunized Population and Administered Doses of all the 10 diseases

  1. Influenza Vaccines
  2. Retrovirus
  3. Hepatitis A & B
  4. Polio
  5. DTaP
  6. HIB
  7. Pneumococcal conjugate
  8. Varicella
  9. MMR
  10. HPV

All the company analysis has been covered from 4 Viewpoints

• Overview
• Recent Developments
• Revenue Analysis
• Vaccinations Pipeline & Clinical Trials

Company Analysis

• GlaxoSmithKline, plc
• Merck & Co
• Sanofi Pasteur
• Pfizer, Inc.

About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s